Latest Funding News

Galan Lithium has locked in a binding funding and offtake agreement with Authium Limited for its Hombre Muerto West project, significantly reducing capital and operating costs. The company raised approximately A$13 million via placement and plans further shareholder funding, aiming for lithium chloride production in H1 2026.

Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.

archTIS has reported a standout March quarter with record annual recurring revenue, improved gross margins, and strategic growth through the Direktiv acquisition and new international contracts.

Future Metals NL has confirmed significant copper-nickel-PGM mineralisation at its Eileen Bore Prospect, unveiling a newly defined 4.5km intrusion. The company also secured A$4.2 million through a placement and planned rights issue to advance development and explore strategic processing partnerships.

Opthea Limited has discontinued its wet AMD development program following Phase III trial failures, slashing its workforce by 65% amid ongoing financial uncertainty and negotiations with investors.

Australian Vanadium Limited reports significant progress across its vertically integrated vanadium strategy, with key project milestones, government approvals, and promising energy storage developments positioning it for growth.

Stockland’s 3Q25 update highlights steady progress on its Waterloo Renewal Project and solid sales in masterplanned communities, supporting maintained FY25 earnings guidance.

Acrow Limited has acquired Brand Australia and Above Scaffolding, significantly boosting its Industrial Access division in New South Wales. Despite short-term contract delays impacting FY25, the company remains optimistic about future growth and synergy opportunities.

Titomic Limited advances its strategic U.S. footprint with a new Huntsville facility set to open in June 2025, securing major defense collaborations and expanding commercial momentum in additive manufacturing.

Tambourah Metals reports promising gold assay results from its Tambourah King drilling program and secures shareholder approval for a strategic acquisition targeting critical minerals at Speewah Nth.

Imugene Limited reports encouraging Phase 1b results for azer-cel in lymphoma, secures FDA Fast Track status, and strengthens patent portfolio while raising A$20 million to fuel ongoing immuno-oncology programs.

Cosmo Metals has completed the acquisition of the Bingara and Nundle gold-antimony-copper projects in NSW and progressed exploration at its Kanowna Gold Project in WA, supported by a $1.1 million capital raise.